Dark

NEPH
Nephros Inc.
stock NASDAQ

At Close

May 9, 2025 3:59:30 PM EDT

1.90USD-4.523%(-0.09)25,043

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-1.99)0

After-hours

May 9, 2025 4:38:30 PM EDT

1.90USD0.000%(0.00)500

OverviewHistoricalExchangesShortsNews

Jan 13, 2022

11:46AM EST Nephros Sees FY22 Revenue $13M-$15M vs $15.66M Est. Benzinga

07:30AM EST via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today issued a 2022 letter to shareholders. GlobeNewswire Inc

Jan 11, 2022

07:35AM EST Nephros Sees Q4 Sales $2.8M Vs. $2.96M Est., FY21 Sales $10.4M Vs. $10.59M Est. Benzinga

07:30AM EST Anticipates Record Full-Year Net Revenue of $10.4 Million, a 21% Year-Over-Year Increase and Fourth Quarter Revenue of $2.8 Million, an 18% Year-Over-Year Increase; Provides 2022 Guidance of $13.0 Million to $13.5 Million in Annual Revenue GlobeNewswire Inc

Nov 23, 2021

04:15PM EST Nephros to Present at the Benchmark Company 10th Annual One-on-One GlobeNewswire Inc

Nov 5, 2021

09:32AM EDT Nephros Q3 EPS $(0.12) Misses $(0.10) Estimate, Sales $2.60M Miss $2.66M Estimate Benzinga

Nov 4, 2021

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Oct 21, 2021

07:30AM EDT viaNewMediaWire Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its third quarter financial results on Thursday, November 4, 2021 after market close and will host a conference call that same day at 4:30 PM ET. GlobeNewswire Inc

Oct 8, 2021

07:31AM EDT Nephros Sees Q3 Sales ~$2.6M vs $2.9M Estimate Benzinga

07:30AM EDT Anticipates Net Revenue of $2.6 Million, a 24% Year-Over-Year Increase GlobeNewswire Inc

Oct 5, 2021

07:30AM EDT Nephros to Present at theLD Micro Main Event GlobeNewswire Inc

Sep 15, 2021

09:39AM EDT Nephros to Present at the Virtual MicroCap Leadership Summit GlobeNewswire Inc

Sep 7, 2021

04:21PM EDT Nephros 8K Filing Shows Registration For Common Stock Offering Of ~124K Shares Benzinga

Sep 1, 2021

07:41AM EDT Nephros Appoints Wes Lobo As Chief Commercial Officer RTTNews

07:30AM EDT viaNewMediaWire --Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced the appointment of Wes Lobo to the role of Chief Commercial Officer. GlobeNewswire Inc

Aug 5, 2021

05:55PM EDT Nephros Q2 Sales $2.30M Miss $2.60M Estimate Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Jul 12, 2021

07:37AM EDT Nephros Announces Acquisition Of GenArraytion RTTNews

07:35AM EDT Nephros Announces Acquisition Of GenArraytion; Terms Not Disclosed Benzinga

07:33AM EDT Strategic Acquisition Accelerates Pathogen Detection Product Development GlobeNewswire Inc

Jul 9, 2021

04:18PM EDT via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, has been invited to present at the Access to Giving Virtual Investor conference, which is being held July 13-15. GlobeNewswire Inc

Jul 8, 2021

09:42AM EDT Nephros Sees 40% Increase In Q2 Sales, Submits HDF Product For FDA Approval Benzinga

07:32AM EDT Anticipates Net Revenue of $2.2 Million, Greater Than 40% Year-Over-Year Increase;Submits HDF Product to FDA for 510(k) Clearance GlobeNewswire Inc

07:32AM EDT Nephros Sees Q2 Sales $2.2M; Announces Co. Submitted HDF Product To FDA For 510(k) Clearence Benzinga

May 6, 2021

05:29PM EDT Nephros Q1 EPS $(0.06) Beats $(0.12) Estimate, Sales $2.74M Beat $2.48M Estimate Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 26, 2021

07:30AM EDT via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial results onThursday, May 6, 2021 after market close and will host a conference call that same day at4:30 PM ET. GlobeNewswire Inc

Apr 5, 2021

07:38AM EDT Nephros Expects Q1 Revenue To Be $2.7 Mln RTTNews

07:31AM EDT Nephros Expects Q1 Sales $2.7M Vs. $2.35M Est. Benzinga

07:30AM EDT Anticipates Net Revenue of $2.7 Million; Highest First Quarter in Company History GlobeNewswire Inc

Mar 16, 2021

07:45AM EDT Nephros to Present at the Q1 Virtual Investor Summit GlobeNewswire Inc

Mar 10, 2021

07:30AM EST Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural GlobeNewswire Inc

Mar 1, 2021

04:57PM EST Recap: Nephros Q4 Earnings Benzinga

04:25PM EST Nephros Q4 Sales $2.30M Miss $2.34M Estimate Benzinga

04:15PM EST Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third QuarterFull Year Revenue $8.6 million, Down 17% Against Prior Year GlobeNewswire Inc

03:51AM EST Earnings Scheduled For March 1, 2021 Benzinga

Feb 22, 2021

07:30AM EST Nephros Announces Fourth Quarter and Full Year 2020 Financial GlobeNewswire Inc

Feb 18, 2021

07:30AM EST Nephros Hires Wes Lobo as Chief Marketing Officer GlobeNewswire Inc

Feb 3, 2021

05:16PM EST Nephros Daniel Dagostino Resigned As CFO, Effective Immediately Benzinga

Jan 26, 2021

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2021 Benzinga

06:13AM EST B. Riley FBR Initiates Coverage On Nephros with Buy Rating, Announces Price Target of $12.5 Benzinga

Jan 12, 2021

07:37AM EST Nephros Expects Revenues For Q4 To Be $2.3 Mln RTTNews

07:31AM EST Nephros Sees Prelim. Q4 Sales $2.3M vs $2.31M Est. Benzinga

07:30AM EST Anticipates $2.3 Million Revenue in Fourth Quarter, $8.5 Million in Full-Year; Quarterly Revenue Grew 9% Sequentially Over Third Quarter; Full Year Revenue Declined 17% GlobeNewswire Inc

Jan 5, 2021

10:55AM EST Update: Nephros Provides Year-End Technology Update, Including HDF GlobeNewswire Inc

Jan 4, 2021

07:36AM EST Nephros Provides Year-End Technology Update Benzinga

07:30AM EST Nephros Provides Year-End Technology Update, Including HDF Program GlobeNewswire Inc

Nov 9, 2020

07:30AM EST via NewMediaWire--Nephros, Inc. (Nasdaq: NEPH),a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets,today announced that it will participate at the following investor conferences in November. GlobeNewswire Inc

Nov 5, 2020

05:57PM EST Nephros Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $2.12M Miss $2.18M Estimate Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Oct 29, 2020

07:30AM EDT Nephros Announces Third Quarter 2020 Financial Results Conference Call GlobeNewswire Inc

Oct 16, 2020

07:50AM EDT Nephros Announces Pricing Of $5 Mln Registered Direct Offering Of Common Stock RTTNews

07:31AM EDT Nephros Prices ~833K Share Offering At $6/Share Benzinga

07:30AM EDT Nephros Announces Pricing of $5 Million Registered Direct Offering GlobeNewswire Inc

Oct 13, 2020

07:34AM EDT Nephros Announces Release Of DialyPath qPCR-based, Real-time, On-Site Endotoxin Assay For Dialysis Water Benzinga

07:30AM EDT via NewMediaWire--Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced availability of DialyPath, an assay that estimates endotoxin levels in dialysis water samples. GlobeNewswire Inc

Oct 7, 2020

07:30AM EDT via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th 16th, 2020. GlobeNewswire Inc

Oct 6, 2020

08:21AM EDT Nephros Sees Q3 Prelim. Sales $2.1M Vs. $2.18M Est. Benzinga

07:39AM EDT Nephros Expects Q3 Net Revenues To Be $2.1 Mln RTTNews

07:34AM EDT Nephros Sees Q3 Prelim. Sales $2.1M Vs. $2.18M Est. Benzinga

07:30AM EDT via NEWMEDIAWIRE Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary financial results for the quarter ended September 30, 2020. GlobeNewswire Inc

Aug 14, 2020

07:32AM EDT Nephros Names Andy Astor President And Chief Executive Officer Benzinga

07:30AM EDT Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal Products GlobeNewswire Inc

Aug 5, 2020

05:06PM EDT Nephros Q2 EPS $(0.19) Misses $(0.15) Estimate, Sales $1.60M Miss $1.74M Estimate Benzinga

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Jul 29, 2020

07:30AM EDT Nephros Announces Second Quarter 2020 Financial Results Conference GlobeNewswire Inc

Jul 22, 2020

07:30AM EDT Nephros SequaPath, a new microbial screening system, used to evaluate 88 building water samples across four US geographic regions GlobeNewswire Inc

Jul 13, 2020

07:30AM EDT Nephros to Present at Zooming with LD GlobeNewswire Inc

.dark-mode .K4BCcy{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .K4BCcy{ color: #333333; background-color: white; border: 2px solid #333333; }NEPHNephros Inc.stock NASDAQ

NEPH
Nephros Inc.
stock NASDAQ